VU
Valence8 US Portfolio holdings
AUM
$238M
This Quarter Return
-2.5%
1 Year Return
+14.65%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$208M
AUM Growth
+$208M
(-9.2%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-6.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
57
New
1
Increased
4
Reduced
5
Closed
31
Top Buys
| 1 |
iShares Expanded Tech-Software Sector ETF
IGV
|
$7.8M |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$266K |
| 3 |
Vanguard Value ETF
VTV
|
$130K |
| 4 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$70.3K |
| 5 |
Utilities Select Sector SPDR Fund
XLU
|
$23.2K |
Top Sells
| 1 |
iShares MSCI Japan ETF
EWJ
|
$3.35M |
| 2 |
iShares MSCI United Kingdom ETF
EWU
|
$3.14M |
| 3 |
Invesco QQQ Trust
QQQ
|
$2.22M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
$1.88M |
| 5 |
iShares MSCI Intl Quality Factor ETF
IQLT
|
$1.33M |
Sector Composition
| 1 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tyra Biosciences
TYRA
$675M
| – | – |
-13,188
| Closed | -$310K |
|
52
Vir Biotechnology
VIR
$686M
| – | – |
-33,650
| Closed | -$252K |
|
53
Viridian Therapeutics
VRDN
$1.5B
| – | – |
0
| – | – |
|
54
VistaGen Therapeutics
VTGN
$102M
| – | – |
-34,376
| Closed | -$103K |
|
55
Zura Bio
ZURA
$133M
| – | – |
-17,495
| Closed | -$71K |
|
56
Zevra Therapeutics
ZVRA
$509M
| – | – |
-21,596
| Closed | -$150K |
|
|
CLYM
57
Climb Bio, Inc. Common Stock
CLYM
$151M
| – | – |
-12,045
| Closed | -$61.3K |
|